Home › Hypertrophic Cardiomyopathy › Massachusetts
Pag-aaral pangklinika para sa Hypertrophic Cardiomyopathy sa Massachusetts
6 pag-aaral para sa Hypertrophic Cardiomyopathy ang naghahanap ng mga kalahok sa mga site sa Massachusetts.
Mga Lungsod sa Massachusetts
Opisyal na teksto ng pag-aaral (English)
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
- Harvard (Massachusetts General Hospital), Boston
- Harvard Medical School - Brigham and Women's Hospital (BWH), Boston
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT05489705Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis
- Tufts Medical Center, Boston
- Boston Medical Center, Boston
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 50 pataas · Lahat ng kasarian · Na-update Hun 4, 2026 · NCT06034405A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy
- Imbria Investigational Site, Boston
- Imbria Investigational Site, Burlington
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update May 18, 2026 · NCT07023614A Gene Therapy Study of RP-A501 in Male Patients With Danon Disease
- Boston Children's Hospital, Boston
Nagre-recruitPhase 2
Edad 8 pataas · Kalalakihan · Na-update May 4, 2026 · NCT06092034HCMR Re-Imaging Study
- Brigham & Women's Hospital, Boston
- Tufts Medical Center, Medford
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Mar 18, 2026 · NCT07054073Real-world Patient Reported Outcomes Among Patients Treated With Camzyos
- Analysis Group Inc., Boston
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 7, 2024 · NCT06551129Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.